Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Association of cardio-ankle vascular index with brain natriuretic peptide levels in hypertension.

Masugata H, Senda S, Inukai M, Murao K, Himoto T, Hosomi N, Murakami K, Noma T, Kohno M, Okada H, Goda F.

J Atheroscler Thromb. 2012;19(3):255-62. Epub 2011 Nov 7.

2.

Association between urinary 8-hydroxydeoxyguanosine, an indicator of oxidative stress, and the cardio-ankle vascular index in hypertensive patients.

Masugata H, Senda S, Murao K, Inukai M, Himoto T, Hosomi N, Okada H, Goda F.

J Atheroscler Thromb. 2012;19(8):747-55. Epub 2012 Apr 28.

3.

Brain natriuretic peptide as a marker for hypertensive left ventricular hypertrophy: changes during 1-year antihypertensive therapy with angiotensin-converting enzyme inhibitor.

Kohno M, Horio T, Yokokawa K, Yasunari K, Ikeda M, Minami M, Kurihara N, Takeda T.

Am J Med. 1995 Mar;98(3):257-65.

PMID:
7872342
4.

Association of new arterial stiffness parameter, the cardio-ankle vascular index, with left ventricular diastolic function.

Sakane K, Miyoshi T, Doi M, Hirohata S, Kaji Y, Kamikawa S, Ogawa H, Hatanaka K, Kitawaki T, Kusachi S, Yamamoto K.

J Atheroscler Thromb. 2008 Oct;15(5):261-8.

5.

Augmentation index is associated with B-type natriuretic peptide in patients with paroxysmal atrial fibrillation.

Kaji Y, Miyoshi T, Doi M, Hirohata S, Kamikawa S, Sakane K, Kitawaki T, Kusachi S, Kusano KF, Ito H.

Hypertens Res. 2009 Jul;32(7):611-6. doi: 10.1038/hr.2009.62. Epub 2009 May 1.

PMID:
19407818
6.

Brain natriuretic peptide as a risk marker for incident hypertensive cardiovascular events.

Suzuki M, Hamada M, Yamamoto K, Kazatani Y, Hiwada K.

Hypertens Res. 2002 Sep;25(5):669-76.

7.

Association between arterial stiffness and pulmonary function in hypertensive patients.

Masugata H, Senda S, Okada H, Murao K, Inukai M, Himoto T, Hosomi N, Murakami K, Noma T, Kohno M, Goda F.

Hypertens Res. 2012 Apr;35(4):388-92. doi: 10.1038/hr.2011.199. Epub 2011 Nov 24.

PMID:
22113357
8.

The limited value of plasma B-type natriuretic peptide for screening for left ventricular hypertrophy among hypertensive patients.

Nakamura M, Tanaka F, Yonezawa S, Satou K, Nagano M, Hiramori K.

Am J Hypertens. 2003 Dec;16(12):1025-9.

PMID:
14643576
9.

Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population.

Luchner A, Burnett JC Jr, Jougasaki M, Hense HW, Heid IM, Muders F, Riegger GA, Schunkert H.

J Hypertens. 2000 Aug;18(8):1121-8.

PMID:
10954005
10.

Cardio-ankle vascular index is independently associated with the severity of coronary atherosclerosis and left ventricular function in patients with ischemic heart disease.

Miyoshi T, Doi M, Hirohata S, Sakane K, Kamikawa S, Kitawaki T, Kaji Y, Kusano KF, Ninomiya Y, Kusachi S.

J Atheroscler Thromb. 2010 Mar 31;17(3):249-58. Epub 2010 Jan 26.

11.

Cardio-ankle vascular index relates to left ventricular ejection fraction in patients with heart failure. A retrospective study.

Zhang C, Ohira M, Iizuka T, Mikamo H, Nakagami T, Suzuki M, Hirano K, Takahashi M, Shimizu K, Sugiyama Y, Yamaguchi T, Kawana H, Endo K, Saiki A, Oyama T, Kurosu T, Tomaru T, Wang H, Noike H, Shirai K.

Int Heart J. 2013;54(4):216-21.

12.

Association of cardio-ankle vascular index with diastolic heart function in hypertensive patients.

Kim H, Kim HS, Yoon HJ, Park HS, Cho YK, Nam CW, Hur SH, Kim YN, Kim KB.

Clin Exp Hypertens. 2014;36(4):200-5. doi: 10.3109/10641963.2013.804544. Epub 2013 Jun 20.

PMID:
23786431
13.

Values of cardio-ankle vascular index (CAVI) between Amami islands and Kagoshima mainland among health checkup examinees.

Hirasada K, Niimura H, Kubozono T, Nakamura A, Tatebo M, Ogawa S, Tsunematsu N, Chiba S, Matsushita T, Kusano K, Miyata M, Takezaki T.

J Atheroscler Thromb. 2012;19(1):69-80. Epub 2011 Nov 21.

14.

Plasma brain natriuretic peptide during ergometric exercise in hypertensive patients with left ventricular hypertrophy.

Kohno M, Yasunari K, Yokokawa K, Horio T, Kano H, Minami M, Ikeda M, Yoshikawa J.

Metabolism. 1996 Nov;45(11):1326-9.

PMID:
8931634
15.

Comparison of central blood pressure and cardio-ankle vascular index for association with cardiac function in treated hypertensive patients.

Masugata H, Senda S, Okuyama H, Murao K, Inukai M, Hosomi N, Yukiiri K, Nishiyama A, Kohno M, Goda F.

Hypertens Res. 2009 Dec;32(12):1136-42. doi: 10.1038/hr.2009.157. Epub 2009 Sep 25.

PMID:
19779490
16.

New insights into the mechanism of the elevation of plasma brain natriuretic polypeptide levels in patients with left ventricular hypertrophy.

Murakami Y, Shimada T, Inoue S, Shimizu H, Ohta Y, Katoh H, Nakamura K, Ishibashi Y.

Can J Cardiol. 2002 Dec;18(12):1294-300.

PMID:
12518181
17.
18.

Usefulness of plasma B-type natriuretic peptide in the assessment of disease severity and prediction of outcome after aortic valve replacement in patients with severe aortic stenosis.

Iwahashi N, Nakatani S, Umemura S, Kimura K, Kitakaze M.

J Am Soc Echocardiogr. 2011 Sep;24(9):984-91. doi: 10.1016/j.echo.2011.03.012. Epub 2011 May 12.

PMID:
21570253
19.

N-terminal pro-B-type natriuretic peptide is associated with arterial stiffness measured using the cardio-ankle vascular index in renal transplant recipients.

Chen YC, Lee MC, Lee CJ, Ho GJ, Yin WY, Chang YJ, Hsu BG.

J Atheroscler Thromb. 2013;20(7):646-53. Epub 2013 May 10.

20.

Diagnostic and prognostic value of plasma brain natriuretic peptide in non-dialysis-dependent CRF.

Takami Y, Horio T, Iwashima Y, Takiuchi S, Kamide K, Yoshihara F, Nakamura S, Nakahama H, Inenaga T, Kangawa K, Kawano Y.

Am J Kidney Dis. 2004 Sep;44(3):420-8.

PMID:
15332214

Supplemental Content

Support Center